Corticosteroid

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was deemed “best predictor” of 12-month remission in patients with severe eosinophilic asthma, according to study data.

Among adults with severe eosinophilic asthma and previous biologic use, benralizumab for 48 weeks aided in reducing exacerbations and improving asthma symptom control, according to results published in European Respiratory Journal.

Less than half of patients with sarcoidosis had been treated by the 1-year mark since being diagnosed with the condition, according to results published in CHEST.

BOSTON — Compared with 17,800 patients starting new inhaled COPD maintenance therapy in 2016, 32,558 patients started a new inhaled treatment in 2022, according to a presentation at the CHEST Annual Meeting.

BOSTON — Asthma control during pregnancy lowers the risk for complications, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Baseline concomitant exposure to commonly used medications, such as corticosteroids and 5-aminosalicylates, did not significantly affect clinical and endoscopic outcomes during induction therapy in ulcerative colitis, data analysis showed.

When diagnosed with COPD, 86.2% of patients did not receive treatment, and after 4 years, 63.8% still had not been treated, according to results published in BMC Pulmonary Medicine.

WASHINGTON — Although even low-dose prednisone significantly increases the risk for fracture in systemic lupus erythematosus, there is no increased risk from intramuscular triamcinolone or intravenous methylprednisolone, said a speaker.

BOSTON — Among adults with COPD starting a new inhaled maintenance treatment, common characteristics included older age and having multiple comorbidities, according to a poster presented at the CHEST Annual Meeting.